Use of Molecular Imaging to Further Investigate PI-RADS 3 Lesions

被引：0
|
作者：
Turkbey, Baris [1 ]
机构：
[1] NCI, Mol Imaging Branch, Natl Inst Hlth, 10Ctr Dr,Room B3B85, Bethesda, MD 20892 USA
来源：
RADIOLOGY | 2024年 / 311卷 / 02期
关键词：
D O I：
10.1148/radiol.240401
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The predictive impact of hematological inflammatory markers in detecting prostate cancer in patients with PI-RADS 3 lesions on multiparametric magnetic resonance imaging
    Kayar, Ridvan
    Tokuc, Emre
    Ozsoy, Emrah
    Demir, Samet
    Kayar, Kemal
    Topaktas, Ramazan
    Demir, Selamettin
    Ozturk, Metin
    PROSTATE, 2024, 84 (13): : 1244 - 1250
  • [42] Clinical Utility of Prostate Health Index for Diagnosis of Prostate Cancer in Patients with PI-RADS 3 Lesions
    Lee, Chung-Un
    Lee, Sang-Min
    Chung, Jae-Hoon
    Kang, Minyong
    Sung, Hyun-Hwan
    Jeon, Hwang-Gyun
    Jeong, Byong-Chang
    Seo, Seong-Il
    Jeon, Seong-Soo
    Lee, Hyun-Moo
    Song, Wan
    CANCERS, 2022, 14 (17)
  • [43] Prognostic significance of PI-RADS 5 lesions in patients treated by radical prostatectomy
    Fiard, G.
    Seigneurin, A.
    Roumiguie, M.
    Albisinni, S.
    Anract, J.
    Assenmacher, G.
    Delongchamps, N. Barry
    Dariane, C.
    Feyaerts, A.
    Fourcade, A.
    Fournier, G.
    Gontero, P.
    Mastroianni, R.
    Oderda, M.
    Peltier, A.
    Roumeguere, T.
    Saussez, T.
    Simone, G.
    Van Damme, J.
    Descotes, J. L.
    Ploussard, G.
    Diamand, R.
    WORLD JOURNAL OF UROLOGY, 2023, 41 (05) : 1285 - 1291
  • [44] MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?
    Schoots, Ivo G.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (01) : 70 - +
  • [45] PSA Density and Lesion Volume: Key Factors in Avoiding Unnecessary Biopsies for PI-RADS 3 Lesions
    Ayranci, Ali
    Caglar, Ufuk
    Yazili, Huseyin Burak
    Erdal, Feyzi Sinan
    Erbin, Akif
    Sarilar, Omer
    Ozgor, Faruk
    PROSTATE, 2025, 85 (04): : 385 - 390
  • [46] Multimodal approach to optimize biopsy decision-making for PI-RADS 3 lesions on multiparametric MRI
    Esengur, Omer Tarik
    Yilmaz, Enis C.
    Ozyoruk, Kutsev B.
    Chen, Alex
    Lay, Nathan S.
    Gelikman, David G.
    Merino, Maria J.
    Gurram, Sandeep
    Wood, Bradford J.
    Choyke, Peter L.
    Harmon, Stephanie A.
    Pinto, Peter A.
    Turkbey, Baris
    CLINICAL IMAGING, 2025, 117
  • [47] Efficacy of plasma atherogenic index in predicting malignancy in the presence of Prostate Imaging-Reporting and Data System 3 (PI-RADS 3) prostate lesions
    Senel, Samet
    Ceviz, Kazim
    Kasap, Yusuf
    Tastemur, Sedat
    Olcucuoglu, Erkan
    Uzun, Emre
    Polat, Muhammed Emin
    Koudonas, Antonios
    Sarialtin, Firathan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (02) : 255 - 261
  • [48] Peri-lesional biopsies increase significant prostate cancer detection in men with PI-RADS 4/5 lesions; validation of the PI-RADS steering committee recommendation
    Doan, Paul
    Kim, Lawrence
    Patel, Manish
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 62 - 63
  • [49] Improving Patient Counselling in Patients' With PI-RADS 3 Lesions with the Use of PSA Density, A Retrospective Study in a UK District General Hospital
    Maniarasu, S.
    Elsayed, M.
    Barker, H.
    BRITISH JOURNAL OF SURGERY, 2023, 110
  • [50] Impact of PI-RADS Category 3 lesions on the diagnostic accuracy of MRI for detecting prostate cancer and the prevalence of prostate cancer within each PI-RADS category: A systematic review and meta-analysis
    Wadera, Akshay
    Alabousi, Mostafa
    Pozdnyakov, Alex
    Al-Ghita, Mohammed Kashif
    Jafri, Ali
    McInnes, Matthew D. F.
    Schieda, Nicola
    van der Pol, Christian B.
    Salameh, Jean-Paul
    Samoilov, Lucy
    Gusenbauer, Kaela
    Alabousi, Abdullah
    BRITISH JOURNAL OF RADIOLOGY, 2021, 94 (1118):
12345